Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
验证沙美特罗替卡松吸入粉雾剂（Salmex）治疗成人支气管哮喘的临床疗效等效于舒利迭，并评价其安全性
CTR20192374Phase 3Completed
- Sponsor
- Celon Pharma S.A.
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salmeterol + fluticasone in asthma, sponsored by Celon Pharma S.A.. Started Jan 2020; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20192374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192374.